Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jul 19;16(14):2628–2647. doi: 10.7150/ijbs.47203

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The author(s)

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.

PMC Copyright notice

Several miRNA-related cancer therapy resistance. There are four categories along with some regulators presented in the text, where the rectangle in green or in red shows whether the function of miRNAs in mentioned cancer type is positive or negative for the corresponding therapy. ERα36: estrogen receptor alpha 36; CYP: cytochrome P450; ABCG2: ATP-binding cassette sub-family G member 2; MDR1: multidrug resistance 1; STAT3: signal transducer and transcriptional activating factor 3; MYC: myelocytomatosis oncogene; HnRNPA1: heterogeneous nuclear ribonucleoprotein A1; PKM2: the Pyruvate kinase muscle 2; mTOR: mammalian target of rapamycin; RPA: replication Protein A; PTEN: phosphatase and tensin homologous protein; ERCC1: excision repair cross-complementing 1.